Simone Barattucci
UCL Queen Square Institute Of Neurology
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
U7 small nuclear RNA splice-switching therapeutics for STMN2 and UNC13A in Amyotrophic Lateral Sclerosis.
Journal: bioRxiv : the preprint server for biology
Published: December 15, 2025
TDP-43 pathology induces CD8+ T cell activation through cryptic epitope recognition.
Journal: bioRxiv : the preprint server for biology
Published: July 16, 2025
Creation of de novo cryptic splicing for ALS and FTD precision medicine.
Journal: Science (New York, N.Y.)
Published: October 03, 2024
Loss of TDP-43 induces synaptic dysfunction that is rescued by UNC13A splice-switching ASOs.
Journal: bioRxiv : the preprint server for biology
Published: July 09, 2024
TDP-43 loss induces extensive cryptic polyadenylation in ALS/FTD.
Journal: bioRxiv : the preprint server for biology
Published: February 05, 2024
TDP-43 loss induces cryptic polyadenylation in ALS/FTD.
Journal: Nature neuroscience
Published: January 15, 2024
TDP-43 loss induces cryptic polyadenylation in ALS/FTD.
Journal: Nature neuroscience
Published: January 15, 2024
TDP-43-dependent mis-splicing of KCNQ2 triggers intrinsic neuronal hyperexcitability in ALS/FTD.
Journal: Nature neuroscience
Published: March 22, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026